Xenon Pharmaceuticals Inc. (XENE)
NASDAQ
Xenon Pharmaceuticals Inc. Revenue 2012–2025
Xenon Pharmaceuticals Inc. annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Xenon Pharmaceuticals Inc. revenue for the quarter ending March 31, 2026 was 0, a 100.00% decrease year-over-year.
- Xenon Pharmaceuticals Inc. revenue for the twelve months ending March 31, 2026 was 7.5 M, a 5581.82% increase year-over-year.
- Xenon Pharmaceuticals Inc. annual revenue for 2025 was 7.5 M.
- Xenon Pharmaceuticals Inc. annual revenue for 2024 was 0.
- Xenon Pharmaceuticals Inc. annual revenue for 2023 was 0, a 100.00% decrease from 2022.
- Xenon Pharmaceuticals Inc. annual revenue for 2022 was 9.4 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Xenon Pharmaceuticals Inc. Earnings — FAQ
Xenon Pharmaceuticals Inc. (XENE) earnings over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XENE's earnings history?
The chart and table above show Xenon Pharmaceuticals Inc.'s earnings by year and by quarter, including the growth rate.